Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma.

British journal of cancer - 1 May 2000

Liu G, Ghadirian P, Vesprini D, Hamel N, Paradis A J, Lal G, Gallinger S, Narod S A, Foulkes W D

Abstract excerpt

A prospective study of 149 unselected incident cases of pancreatic adenocarcinoma and 146 ethnically-matched controls found no associations between GSTM1 (adjusted odds ratio (AOR) 1.14), GSTT1 (AOR: 1.19) and CYP1A1 (AOR: 1.08) polymorphisms and pancreatic cancer susceptibility. Smoking and drinking status did not affect results. These polymorphisms do not appear to be important gene modifiers in pancreatic cancer.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged, 80 and over
Share to Cytochrome P-450 CYP1A1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutathione Transferase

Share to Odds Ratio

Share to Pancreatic Neoplasms

Share to Regression Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 10817498
DOI: 10.1054/bjoc.2000.1221
PMCID: PMC2374522

Genes

GSTM1
GSTT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma.PMID 10817498Read ↗

Associations of GSTM1 and GSTT1 polymorphisms with pancreatic cancer risk: evidence from a meta-analysis.Semantic proximity Read ↗

Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-institutional case-control study in Japan.Semantic proximity Read ↗

MTHFR polymorphisms and pancreatic cancer risk: lack of evidence from a meta-analysis.Semantic proximity Read ↗

GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas.Semantic proximity Read ↗

Significant association between GSTT1 null genotype and susceptibility to pancreatic cancer.Semantic proximity Read ↗

Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group.Semantic proximity Read ↗

CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk.Semantic proximity Read ↗

Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer.Semantic proximity Read ↗

No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition.Semantic proximity Read ↗

Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer.Semantic proximity Read ↗

DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.